Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Arcutis Biotherapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-07-18
Sale
2022-07-18
6:53 pm
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
6,000 $24.4 $146,374 205,199
(Indirect
Direct)
View
2022-07-08
Sale
2022-07-12
7:30 pm
Arcutis Biotherapeutics Inc. ARQT OSBORNE DAVID W
CTO
2,197 $25.41 $55,835 256,649
(Direct)
View
2022-07-08
Sale
2022-07-12
7:30 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
13,500 $25.37 $342,473 981,733
(Indirect
Direct)
View
2022-07-06
Sale
2022-07-07
4:04 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $22.07 $22,070 876,298
(Indirect
Direct)
View
2022-06-24
Sale
2022-06-28
4:29 pm
Arcutis Biotherapeutics Inc. ARQT ORBIMED ADVISORS LLC
ORBIMED CAPITAL LLC
OrbiMed Capital GP VII LLC
10% Owner
341,971 $21.31 $7,287,402 415,142
(Indirect)
View
2022-06-06
Sale
2022-06-06
4:06 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $21.06 $21,064 877,298
(Indirect
Direct)
View
2022-05-27
Sale
2022-06-02
4:48 pm
Arcutis Biotherapeutics Inc. ARQT Matsuda Masaru
VP
1,795 $19.73 $35,419 16,380
(Direct)
View
2022-06-01
Sale
2022-06-02
4:48 pm
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
2,500 $20.62 $51,539 248,365
(Indirect
Direct)
View
2022-05-05
Sale
2022-05-05
5:31 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $21.76 $21,760 876,681
(Indirect
Direct)
View
2022-05-02
Sale
2022-05-03
5:14 pm
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
2,500 $20.44 $51,112 256,975
(Indirect
Direct)
View
2022-04-21
Sale
2022-04-21
6:32 pm
Arcutis Biotherapeutics Inc. ARQT OSBORNE DAVID W
CTO
2,197 $20.42 $44,872 257,229
(Direct)
View
2022-04-06
Sale
2022-04-08
6:06 pm
Arcutis Biotherapeutics Inc. ARQT ORBIMED ADVISORS LLC
ORBIMED CAPITAL LLC
OrbiMed Capital GP VII LLC
10% Owner
878,200 $20.68 $18,163,608 451,086
(Indirect)
View
2022-04-05
Sale
2022-04-05
6:45 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $21.43 $21,430 877,681
(Indirect
Direct)
View
2022-04-01
Sale
2022-04-01
4:55 pm
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
7,500 $20.02 $150,184 214,493
(Indirect
Direct)
View
2022-03-09
Sale
2022-03-11
9:42 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
300 $17 $5,100 878,681
(Indirect
Direct)
View
2022-03-03
Sale
2022-03-07
8:59 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
3,259 $16.9 $55,088 1,186,016
(Indirect
Direct)
View
2022-03-03
Sale
2022-03-07
8:53 pm
Arcutis Biotherapeutics Inc. ARQT Burnett Patrick
See Remarks
1,011 $16.85 $17,032 90,139
(Direct)
View
2022-03-03
Sale
2022-03-07
8:49 pm
Arcutis Biotherapeutics Inc. ARQT Lock Kenneth A.
Chief Commercial Officer
1,023 $16.85 $17,234 79,311
(Direct)
View
2022-03-03
Sale
2022-03-07
8:49 pm
Arcutis Biotherapeutics Inc. ARQT Burrows Scott L
CFO
303 $16.85 $5,104 70,556
(Direct)
View
2022-03-03
Sale
2022-03-07
8:48 pm
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
1,023 $16.85 $17,234 66,413
(Direct)
View
2022-03-03
Sale
2022-03-07
8:47 pm
Arcutis Biotherapeutics Inc. ARQT OSBORNE DAVID W
CTO
856 $16.85 $14,420 294,726
(Direct)
View
2022-03-01
Sale
2022-03-03
4:18 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
2,153 $17.75 $38,222 810,640
(Indirect
Direct)
View
2022-03-01
Sale
2022-03-03
4:18 pm
Arcutis Biotherapeutics Inc. ARQT OSBORNE DAVID W
CTO
775 $17.75 $13,758 246,982
(Direct)
View
2022-03-01
Sale
2022-03-03
4:17 pm
Arcutis Biotherapeutics Inc. ARQT Burrows Scott L
CFO
420 $17.75 $7,456 22,259
(Direct)
View
2022-03-01
Sale
2022-03-03
4:16 pm
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
936 $17.75 $16,617 18,836
(Direct)
View
2022-03-01
Sale
2022-03-03
4:15 pm
Arcutis Biotherapeutics Inc. ARQT Lock Kenneth A.
Chief Commercial Officer
935 $17.75 $16,599 31,734
(Direct)
View
2022-02-09
Sale
2022-02-11
5:55 pm
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $17 $17,000 932,428
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-23(A)
Exercise
2022-08-04
8:42 pm
N/A
2029-11-20
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
15,331 $0 191,056
(Direct)
View
2022-03-23(A)
Exercise
2022-08-04
8:42 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
15,331 $6.52 191,056
(Direct)
View
2022-07-08
Exercise
2022-07-12
7:30 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
7,087 $0 981,733
(Direct)
View
2022-07-08
Exercise
2022-07-12
7:30 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
7,087 $1.6806 981,733
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:58 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT Curran Terrie
Director
16,108 $0 16,108
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:57 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT CHAUDHURI BHASKAR
Director
16,108 $0 907,480
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:56 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT Gilbert Halley E
Director
16,108 $0 16,108
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:55 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
16,108 $0 222,995
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:54 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT LIN SUE-JEAN
Director
16,108 $0 16,408
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:53 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT Heron Patrick J
Director
10% Owner
16,108 $0 16,108
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:52 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT Leonard Keith R
Director
16,108 $0 17,858
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:51 pm
N/A
2032-06-01
Arcutis Biotherapeutics Inc. ARQT TURNER JOSEPH L
Director
16,108 $0 16,108
(Direct)
View
2022-05-27
Option Award
2022-06-02
4:48 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Matsuda Masaru
VP
4,875 $0 16,380
(Direct)
View
2022-06-01
Exercise
2022-06-02
4:48 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
2,500 $0 248,365
(Direct)
View
2022-06-01
Exercise
2022-06-02
4:48 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
2,500 $1.6806 248,365
(Direct)
View
2022-05-02
Exercise
2022-05-03
5:14 pm
N/A
2028-06-13
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
2,500 $0 256,975
(Direct)
View
2022-05-02
Exercise
2022-05-03
5:14 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
1,496 $0.5802 256,975
(Direct)
View
2022-05-02
Exercise
2022-05-03
5:14 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
1,004 $1.6806 256,975
(Direct)
View
2022-04-01
Exercise
2022-04-01
4:55 pm
N/A
2028-06-13
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
7,500 $0 214,493
(Direct)
View
2022-04-01
Exercise
2022-04-01
4:55 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Welgus Howard G.
Director
7,500 $0.5802 214,493
(Direct)
View
2022-03-23(A)
Exercise
2022-03-30
8:02 pm
N/A
2029-11-20
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
25,328 $0 191,056
(Direct)
View
2022-03-23(A)
Exercise
2022-03-30
8:02 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
25,328 $6.52 191,056
(Direct)
View
2022-03-23
Option Award
2022-03-25
4:11 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
25,328 $6.52 191,056
(Direct)
View
2022-03-23
Disposition
2022-03-25
4:11 pm
N/A
2029-11-20
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
25,328 $0 191,056
(Direct)
View
2022-03-03
Exercise
2022-03-07
8:59 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
700 $0 1,186,016
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:59 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
259,000 $0 1,186,016
(Direct)
View
2022-03-03
Exercise
2022-03-07
8:59 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
700 $1.6806 1,186,016
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:53 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Burnett Patrick
See Remarks
64,900 $0 90,139
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:52 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Matsuda Masaru
VP
48,600 $0 48,600
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:49 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Lock Kenneth A.
Chief Commercial Officer
48,600 $0 79,311
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:49 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Burrows Scott L
CFO
48,600 $0 70,556
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:48 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Turney Patricia A.
VP
48,600 $0 66,413
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:47 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT OSBORNE DAVID W
CTO
48,600 $0 294,726
(Direct)
View
2022-03-03
Option Award
2022-03-07
8:46 pm
N/A
2032-03-03
Arcutis Biotherapeutics Inc. ARQT Moore Matthew Richard
SVP and Chief Business Officer
48,600 $0 48,600
(Direct)
View
2022-02-09
Exercise
2022-02-11
5:55 pm
N/A
2029-03-13
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $0 932,428
(Direct)
View
2022-02-09
Exercise
2022-02-11
5:55 pm
N/A
N/A
Arcutis Biotherapeutics Inc. ARQT Watanabe Todd Franklin
CEO
1,000 $1.6806 932,428
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next